The unmet critical need for concussion drug therapies

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.   

In this episode, Megan Thomas is in conversation with CEO of Oxeia, Dr Michael  Wyand, where we talk about Oxeia’s work; the unmet critical need for concussion drug therapies; the challenges facing them, including in clinical trials and investment; the potential market for concussion drugs, and more.

You can now, and find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.